polyamide
-
Protected: Bioplastics to enter 2023 with a strong capacity surge
.
There is no excerpt because this is a protected post.
-
Bioplastic, Biorefinery, Company initiatives, Investments, Partnership, Press Release, Tecnon OrbiChemProtected: Bio-based commodity chemicals in the spotlight
.
There is no excerpt because this is a protected post.
-
Protected: Arkema continues bio-polyamide plant construction in Singapore
.
There is no excerpt because this is a protected post.
-
Bio-based chems market sees setback with Rennovia exit
.
We just published our Glucaric Acid Chemical profile last Tuesday for Tecnon OrbiChem’s Biomaterials newsletter (note: subscription required), but unfortunately, we were not able to include this news about Rennovia’s exit until I read about it today from Biofuel Digest. According to the article, Santa Clara, California-based Rennovia ceased its operations (I am not sure when exactly)…
-
Genomatica, Aquafil in bio-nylon collaboration
.
Genomatica and Italy-based polyamide producer Aquafil announced yesterday their collaboration in the development of sugar-based caprolactam, a key raw material in the production of polyamide 6, using Genomatica’s bioprocess GENO CPL. According to the press release, caprolactam has a worldwide market of over 5m tons/year. Of course, I will report more about the current market…
-
VIDEO: Arkema celebrates 70 years of Rilsan PA11
.
Hello blog readers. It is unbelievable that the second half of the year is almost upon us and 2017 actually marks the 10-year anniversary of the Green Chemicals Blog (late September 2017 to be exact). It has certainly been through some ups and downs riding in the wave of the renewable chemicals market and my…
-
Bio-based polyamides update
.
I’ve been always monitoring activities from the bio-polyamides sector as I consider the nylon industry a high-potential area for bio-based chemicals. Here’s a slide from a presentation I gave early this year featuring various building blocks and intermediates required to produce a certain polyamide. The green arrows indicate current R&D/commercial production for bio-based alternatives. But of course,…